hotspot -WSS

hotspot

author：explore 2025-09-30 03:26:20 - browse：41468

AstraZeneca said Friday it will buy up a group of early-stage gene therapies from Pfizer, bucking a trend of drugmakers axing programs and exiting a field that had once captured the imagination — and checkbooks — of many pharmaceutical executives.

AstraZeneca will pay Pfizer up to $1 billion plus royalties for the portfolio of treatments, none of which has entered clinical trials yet. The companies did not say how much it is paying upfront.

The moves come six months after Pfizer said it would stop much of its work on early-stage gene therapy programs, in which researchers try to deliver replacement genes encased in small, non-pathogenic bugs called adeno-associated viruses, or AAVs. Instead, it would focus on newer technologies, such as gene editing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Plastic surgeons increase patient psychiatric screenings

WSS

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

When a patient nears the end, a feared therapy can comfort

Virtual Event: March of the Biosimilars

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Methadone treatment changes are coming. Do they go far enough?

Scientists grapple with ethics of stem cell research

focus

hotspot

leisure time

The high cost of giving birth even with insurance

U.K. researchers warn about biases in medical devices, algorithms

United colonoscopy coverage change 'may cost lives,' doctors say

UnitedHealth increases loan offers after Change Healthcare outage

Sports medicine is finally prioritizing gender equality

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Hepatitis C has a cure — but many Americans still lack access to it

A new ‘biological computer' targets cancer while sparing healthy cells

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

hotspot

Stanford president’s abrupt resignation sparks debate

U.K. researchers warn about biases in medical devices, algorithms

Caribou posts encouraging results on off

Delta passengers in Vegas fall sick while waiting on flight in triple

Physicians and social media: If you see something, say something?

Nurses recount patients attacks

focus

Wikipedia

entertainment

entertainment